Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Induction in Moderate to Severe Crohn's Disease
NCT01393626Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of tofacitinib oral solution in Crohn's disease, sponsored by Pfizer. Started Oct 2011; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01393626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393626.